Blog

We are now offering the FDA-approved and insurance-covered treatment, Esketamine (Spravato), at The Neuropsychiatry and TMS Group. Esketamine is a molecule that is the mirror image of the better-known ketamine. Ketamine was initially FDA-approved as an anesthetic to be used during surgical procedures. In the early 2000s, it was studied...

Depression sufferers who can't take medication can use new technology that improves symptoms By: Wendy Ryan TAMPA, Fla. — Depression is often treated with medication, but a new technological advancement provides new hope for those who can't take antidepressants. "It's an FDA-approved treatment for depression. It was approved in 2008....

Transcranial Magnetic Stimulation (TMS) technology received FDA-approval in 2008 to treat depression patients whose symptoms are non-responsive to antidepressant medications. Historically, depression has been difficult to treat in about half of all diagnosed patients, marking TMS treatment as an extremely important development for the field of psychiatry. Let us imagine a new patient...

Program of Enhanced Psychiatric (PEP) Services for Patients with Brain Injury & Neuropsychiatric Disturbances (NPD): A Proposed Model of Care Faizi Ahmed, M.D., Kathleen Bechtold, Ph.D., Gwenn Smith, Ph.D., Durga Roy, M.D., Anita Everett, M.D., Vani Rao, M.D. Abstract Neuropsychiatric disturbances associated with brain injury occur frequently and are a...

TBI occurs when physical trauma to the head results in injury to the underlying brain. A concussion is a mild severity TBI. As an example, a person who is playing football can hit their head on the field but have no injury to the brain. Although this is a head...

What is depression? There are several criteria that psychiatrists use to make a diagnosis of depression. The most important are when some has depressed, sad, or low mood for the majority of each day and nearly every day of the week. A person with depression also has difficulty feeling joy....